Mellert J, Hering B J, Liu X, Brandhorst D, Brandhorst H, Brendel M, Ernst E, Gramberg D, Bretzel R G, Hopt U T
Department of Surgery, University of Rostock, Germany.
Transplantation. 1998 Jul 27;66(2):200-4. doi: 10.1097/00007890-199807270-00010.
Because of its anatomical and physiological similarities to humans, the pig appears to be a suitable large animal model for preclinical studies of islet transplantation. The aim of this study was to investigate islet auto- and allotransplantation in a pig model with diabetes induced by total pancreatectomy.
Porcine islets were isolated by a continuous digestion-filtration device at 32 degrees C and purified by a discontinuous iso-osmolar Ficoll-sodium-diatrizoate gradient on a Cobe 2991. The purified islets were autografted into the liver or the renal subcapsular space. The liver appears to be a more suitable site for the islet grafts than the renal subcapsular space, and the minimal amount of islets for reversal of diabetes is >5 microl/kg of body weight.
Persistent normoglycemia (fasting blood glucose level: 72.4+/-44.38 mg/dl) with a normal insulin secretion response to glucose stimulation was successfully achieved in five of six diabetic pigs by implanting a sufficient islet mass into the liver. Triple-drug immunosuppressive therapy with cyclosporine, azathioprine, and prednisolone did not prevent porcine islet allografts from experiencing early failure. However, the addition of 15-deoxyspergualin to the triple-drug immunosuppressive regimen significantly prolonged the function of the islet allografts. When antithymocyte globulin was added to the above-mentioned immunosuppressive drug regimen, the normoglycemic period was prolonged to more than 1 month (fasting blood glucose level: 75.4+/-17 mg/dl).
We conclude that autotransplantation with a sufficient islet mass can induce normoglycemia with a normal insulin secretion response to glucose stimulation in pancreatectomized diabetic pigs and that allotransplantation can be successfully achieved when 15-deoxyspergualin and antithymocyte globulin are combined with the triple-drug immunosuppression described above. However, this immunosuppressive protocol results in a high rate of infectious complications.
由于猪在解剖学和生理学上与人类相似,它似乎是胰岛移植临床前研究的合适大型动物模型。本研究的目的是在全胰切除诱导糖尿病的猪模型中研究胰岛自体移植和同种异体移植。
猪胰岛在32℃下通过连续消化过滤装置分离,并在Cobe 2991上通过不连续等渗Ficoll-泛影酸钠梯度纯化。纯化后的胰岛自体移植到肝脏或肾被膜下间隙。肝脏似乎比肾被膜下间隙更适合作为胰岛移植的部位,逆转糖尿病所需的最小胰岛量>5微升/千克体重。
通过向肝脏植入足够量的胰岛,六只糖尿病猪中有五只成功实现了持续正常血糖(空腹血糖水平:72.4±44.38毫克/分升),且对葡萄糖刺激有正常的胰岛素分泌反应。环孢素、硫唑嘌呤和泼尼松龙的三联免疫抑制疗法未能防止猪胰岛同种异体移植早期失败。然而,在三联免疫抑制方案中加入15-去氧精胍菌素可显著延长胰岛同种异体移植的功能。当将抗胸腺细胞球蛋白加入上述免疫抑制药物方案时,正常血糖期延长至1个月以上(空腹血糖水平:75.4±17毫克/分升)。
我们得出结论,在全胰切除的糖尿病猪中,植入足够量的胰岛进行自体移植可诱导正常血糖,并对葡萄糖刺激有正常的胰岛素分泌反应;当15-去氧精胍菌素和抗胸腺细胞球蛋白与上述三联免疫抑制联合使用时,同种异体移植可成功实现。然而,这种免疫抑制方案导致感染并发症的发生率很高。